Morabito Margot, Solary Eric, Selimoglu-Buet Dorothée
INSERM U1287, Gustave Roussy Cancer Center, Villejuif, France; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.
INSERM U1287, Gustave Roussy Cancer Center, Villejuif, France; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.
STAR Protoc. 2025 Aug 4;6(3):104009. doi: 10.1016/j.xpro.2025.104009.
Immature granulocytes (iGRANs) circulating in the peripheral blood of patients with a chronic myeloid malignancy, such as chronic myelomonocytic leukemia, are immunosuppressive cells that promote disease progression. Here, we present a multiparameter flow cytometry-based protocol to quantify iGRANs among peripheral blood mononucleated cells (PBMCs). We describe steps for collecting and labeling PBMCs. We describe the gating strategy to quantify iGRANs as a fraction of myeloid cells or as an absolute number of circulating cells, which supports patient stratification and monitoring. For complete details on the use and execution of this protocol, please refer to Deschamps et al..
在慢性髓系恶性肿瘤患者(如慢性粒单核细胞白血病患者)外周血中循环的未成熟粒细胞(iGRANs)是促进疾病进展的免疫抑制细胞。在此,我们提出一种基于多参数流式细胞术的方案,用于定量外周血单核细胞(PBMCs)中的iGRANs。我们描述了收集和标记PBMCs的步骤。我们描述了将iGRANs定量为髓系细胞一部分或作为循环细胞绝对数量的门控策略,这有助于患者分层和监测。有关本方案使用和执行的完整详细信息,请参考Deschamps等人的文献。